For the previous 10 years Dr. Leary was a tenured Professor of Internal Medicine (Division of Infectious Diseases), Pathology, Biophysics, Microbiology & Immunology, and Human Biological Chemistry & Genetics as well as an Assistant Director of the Biomedical Engineering Center, an Affiliated Senior Scientist in the Sealy Centers for Molecular Sciences, Structural Biology, Cancer Cell Biology, Vaccine Development, and the Program in Bioinformatics at the University of Texas Medical Branch in Galveston, Texas. He also served as Director of Institutional Development for multidisciplinary and multi-institutional research grant development and then Assistant Vice President of Research for Advanced Technology. Prior to this position Dr. Leary was an Assistant and Associate Professor of Experimental Pathology at the University of Rochester Medical School in Rochester, New York.
Dr. Leary's research and teaching career as a professor spans more than 29 years. His original training includes an aerospace engineering degree from M.I.T., a masters degree in astrophysics, and a Ph.D. in Biophysics from Penn State University with a postdoctoral fellowship in Immunology & Cytometry at Los Alamos National Laboratory. His research has been funded by NIH for more than 25 years. He is the holder of 7 issued U.S. Patents, with 4 currently pending and is the author of numerous papers in the fields of high-throughput technologies, rare-event analysis methods, minimal residual disease monitoring, developmental immunology, cancer research, and nanomedicine. Dr. Leary has served on numerous national expert review panels for more than 20 years and is a frequently invited speaker at national and international scientific conferences. He was elected to the College of Fellows, American Institute for Medical and Biological Engineering in 2007.
Dr. Leary’s current funded research spans three general areas: (1) development of new high-throughput (flow cytometry, interactive molecular imaging) technologies for minimal residual disease monitoring, stem/progenitor and cancer stem cell isolation and manipulation, (2) detection of pathogens by hybrid microfluidic flow/imaging and (3) smart bionano-engineered systems for single-cell drug/gene delivery for regenerative nanomedicine.
As part of the research related to his talk at this scientific conference he has been developing multilayered, smart nanosystems containing cell targeting, entry facilitation, and localization molecules with molecular biosensors controlling delivery of therapeutic genes into single cells - the subject of a number of peer-reviewed publications and pending patents.
Cite this work
Researchers should cite this work as follows:
Centre for Cellular and Molecular Biology, Hyderabad, India
- drug delivery
- gene delivery
- gene therapy
- drug delivery